CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway.

Wang, Li-Le; Hu, Rui-Cheng; Dai, Ai-Guo; Tan, Shuang-Xiang; Xu, Ming; Kong, Chun-Chu; Chen, Yun-Rong; Fu, Dai-Yan

Wang, Li-Le; Hu, Rui-Cheng; Dai, Ai-Guo; Tan, Shuang-Xiang; Xu, Ming; Kong, Chun-Chu; Chen, Yun-Rong; Fu, Dai-Yan.

Afiliación

Wang LL; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Hu RC; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Dai AG; Department of Respiratory Diseases, Medical School, Hunan University of Chinese Medicine Changsha 410208, China.
Tan SX; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Xu M; Department of Gastroenterology Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Kong CC; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Chen YR; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.
Fu DY; Department of Respiratory Medicine, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University Changsha 410016, China.

Am J Transl Res ; 13(6): 6279-6287, 2021.

Article en En | MEDLINE | ID: mdl-34306367

Palabras clave

Bcl-2; CHOP; JNK; NSCLC; apoptosis; cisplatin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Transl Res Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google